NCT00645164View on ClinicalTrials.gov

Clinical Evaluation of the Photoallergy Potential of Xenaderm Ointment

PHASE1CompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

May 31, 2008

Study Completion Date

June 30, 2008

Conditions
Healthy
Interventions
OTHER

Ointment Vehicle

Subject acts as own control. 20 mg under Finn chambers

DRUG

Xenaderm

20 mg under Finn chambers

Trial Locations (1)

Unknown

Suncare Research Laboratories, Winston-Salem

Sponsors

Lead Sponsor

Healthpoint
All Listed Sponsors
lead

Healthpoint

INDUSTRY